Form 4 Filing for Protalix BioTherapeutics, Inc.

This filing details a Form 4 filed by Aharon Schwartz, a director at Protalix BioTherapeutics, Inc. (PLX). On September 3, 2026, Schwartz acquired 17,000 stock options and 8,500 restricted stock units (RSUs). The stock options, with an exercise price of $2.59, vest in 12 equal quarterly installments. The underlying securities for both are common stock. The filing also includes a Power of Attorney document, appointing Joseph R. Magnas as attorney-in-fact to execute and file insider trading forms (Forms 3, 4, and 5) on behalf of Schwartz. This power of attorney remains effective until Schwartz is no longer required to file these forms or until it is revoked in writing. The power of attorney was executed on September 2, 2026.